{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:12:20Z","timestamp":1789737140447,"version":"4.0.1"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s13105-025-01116-4","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T03:14:45Z","timestamp":1755573285000},"page":"901-923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ceramides in non-communicable diseases: pathways, nutritional modulation, and therapeutic opportunities"],"prefix":"10.1007","volume":"81","author":[{"given":"Marcia","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Alvarenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia Soares","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Mafra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila F.M.F.","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"1116_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/NRM.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19:175\u2013191. https:\/\/doi.org\/10.1038\/NRM.2017.107","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1116_CR2","doi-asserted-by":"publisher","unstructured":"Gaggini M, Pingitore A, Vassalle C (2021) Plasma ceramides pathophysiology, measurements, challenges, and opportunities. Metabolites 11. https:\/\/doi.org\/10.3390\/METABO11110719","DOI":"10.3390\/METABO11110719"},{"key":"1116_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/NRC3398","volume":"13","author":"SAF Morad","year":"2013","unstructured":"Morad SAF, Cabot MC (2013) Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13:51\u201365. https:\/\/doi.org\/10.1038\/NRC3398","journal-title":"Nat Rev Cancer"},{"key":"1116_CR4","doi-asserted-by":"publisher","unstructured":"Gaggini M, Ndreu R, Michelucci E, Rocchiccioli S, Vassalle C (2022) Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/IJMS23052719","DOI":"10.3390\/IJMS23052719"},{"key":"1116_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/J.BBAMEM.2014.11.018","volume":"1848","author":"J Stiban","year":"2015","unstructured":"Stiban J, Perera M (2015) Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis. Biochim Biophys Acta 1848:561\u2013567. https:\/\/doi.org\/10.1016\/J.BBAMEM.2014.11.018","journal-title":"Biochim Biophys Acta"},{"key":"1116_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.CELREP.2018.12.031","volume":"26","author":"SM Turpin-Nolan","year":"2019","unstructured":"Turpin-Nolan SM, Hammerschmidt P, Chen W, Jais A, Timper K, Awazawa M, Brodesser S, Br\u00fcning JC (2019) CerS1-Derived C18:0 ceramide in skeletal muscle promotes Obesity-Induced insulin resistance. Cell Rep 26:1\u201310e7. https:\/\/doi.org\/10.1016\/J.CELREP.2018.12.031","journal-title":"Cell Rep"},{"key":"1116_CR7","doi-asserted-by":"publisher","unstructured":"Budreviciute S, Damiati DK, Sabir K, Onder P, Schuller-Goetzburg G, Plakys A, Katileviciute S, Khoja R, Kodzius (2020) Management and prevention strategies for Non-communicable diseases (NCDs) and their risk factors. Front Public Health 8. https:\/\/doi.org\/10.3389\/FPUBH.2020.574111","DOI":"10.3389\/FPUBH.2020.574111"},{"key":"1116_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0021-9258(18)52461-3","volume":"266","author":"MY Kim","year":"1991","unstructured":"Kim MY, Linardic C, Obeid L, Hannun Y (1991) Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 266:484\u2013489. https:\/\/doi.org\/10.1016\/S0021-9258(18)52461-3","journal-title":"J Biol Chem"},{"key":"1116_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1083\/JCB.201102051","volume":"194","author":"Z Khavandgar","year":"2011","unstructured":"Khavandgar Z, Poirier C, Clarke CJ, Li J, Wang N, McKee MD, Hannun YA, Murshed M (2011) A cell-autonomous requirement for neutral Sphingomyelinase 2 in bone mineralization. J Cell Biol 194:277\u2013289. https:\/\/doi.org\/10.1083\/JCB.201102051","journal-title":"J Cell Biol"},{"key":"1116_CR10","doi-asserted-by":"publisher","unstructured":"Strum JC, Ghosh S, Bell RM (1997) Lipid Second Messengers 421\u2013431. https:\/\/doi.org\/10.1007\/978-1-4899-1813-0_63","DOI":"10.1007\/978-1-4899-1813-0_63"},{"key":"1116_CR11","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1172\/JCI97949","volume":"128","author":"M Trayssac","year":"2018","unstructured":"Trayssac M, Hannun YA, Obeid LM (2018) Role of sphingolipids in senescence: implication in aging and age-related diseases. J Clin Invest 128:2702\u20132712. https:\/\/doi.org\/10.1172\/JCI97949","journal-title":"J Clin Invest"},{"key":"1116_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1073\/PNAS.91.1.73","volume":"91","author":"WD Jarvis","year":"1994","unstructured":"Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci U S A 91:73\u201377. https:\/\/doi.org\/10.1073\/PNAS.91.1.73","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1116_CR13","doi-asserted-by":"publisher","unstructured":"Back MJ, Ha HC, Fu Z, Choi JM, Piao Y, Won JH, Jang JM, Shin IC, Kim DK (2018) Activation of neutral Sphingomyelinase 2 by starvation induces cell-protective autophagy via an increase in Golgi-localized ceramide. Cell Death Dis 9. https:\/\/doi.org\/10.1038\/S41419-018-0709-4","DOI":"10.1038\/S41419-018-0709-4"},{"key":"1116_CR14","doi-asserted-by":"publisher","first-page":"44749","DOI":"10.1074\/JBC.M112.378836","volume":"287","author":"L Dobierzewska","year":"2012","unstructured":"Dobierzewska L, Shi AA, Karakashian MN, Nikolova-Karakashian (2012) Interleukin 1\u03b2 regulation of FoxO1 protein content and localization: evidence for a novel ceramide-dependent mechanism. J Biol Chem 287:44749\u201344760. https:\/\/doi.org\/10.1074\/JBC.M112.378836","journal-title":"J Biol Chem"},{"key":"1116_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/ACS.JMEDCHEM.0C01664","volume":"64","author":"J Sk\u00e1cel","year":"2021","unstructured":"Sk\u00e1cel J, Slusher BS, Tsukamoto T (2021) Small molecule inhibitors targeting biosynthesis of ceramide, the central hub of the sphingolipid network. J Med Chem 64:279\u2013297. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.0C01664","journal-title":"J Med Chem"},{"key":"1116_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/J.PLIPRES.2016.04.001","volume":"63","author":"Kihara","year":"2016","unstructured":"Kihara (2016) Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides. Prog Lipid Res 63:50\u201369. https:\/\/doi.org\/10.1016\/J.PLIPRES.2016.04.001","journal-title":"Prog Lipid Res"},{"key":"1116_CR17","doi-asserted-by":"publisher","first-page":"14015","DOI":"10.3390\/IJMS241814015","volume":"24","author":"SM Hammad","year":"2023","unstructured":"Hammad SM, Lopes-Virella MF (2023) Circulating sphingolipids in insulin resistance, diabetes and associated complications. Int J Mol Sci 2023 24:14015. https:\/\/doi.org\/10.3390\/IJMS241814015","journal-title":"Int J Mol Sci 2023"},{"key":"1116_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/ANNUREV-PHYSIOL-031620-093815","volume":"83","author":"B Chaurasia","year":"2021","unstructured":"Chaurasia B, Summers SA (2021) Ceramides in metabolism: key lipotoxic players. Annu Rev Physiol 83:303\u2013330. https:\/\/doi.org\/10.1146\/ANNUREV-PHYSIOL-031620-093815","journal-title":"Annu Rev Physiol"},{"key":"1116_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0891-5849(01)00655-4","volume":"31","author":"N Andrieu-Abadie","year":"2001","unstructured":"Andrieu-Abadie N, Gouaz\u00e9 V, Salvayre R, Levade T (2001) Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic Biol Med 31:717\u2013728. https:\/\/doi.org\/10.1016\/S0891-5849(01)00655-4","journal-title":"Free Radic Biol Med"},{"key":"1116_CR20","doi-asserted-by":"publisher","first-page":"16802","DOI":"10.1038\/S41598-020-73912-5","volume":"10","author":"F Al-Rashed","year":"2020","unstructured":"Al-Rashed F, Ahmad Z, Thomas R, Melhem M, Snider AJ, Obeid LM, Al-Mulla F, Hannun YA, Ahmad R (2020) Neutral Sphingomyelinase 2 regulates inflammatory responses in monocytes\/macrophages induced by TNF-\u03b1. Sci Rep 10:16802. https:\/\/doi.org\/10.1038\/S41598-020-73912-5","journal-title":"Sci Rep"},{"key":"1116_CR21","doi-asserted-by":"publisher","unstructured":"Yepes M (2015) Tissue-type plasminogen activator is a neuroprotectant in the central nervous system. Front Cell Neurosci 9. https:\/\/doi.org\/10.3389\/FNCEL.2015.00304","DOI":"10.3389\/FNCEL.2015.00304"},{"key":"1116_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0968-0004(00)01674-1","volume":"25","author":"BH Raha","year":"2000","unstructured":"Raha BH, Robinson (2000) Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 25:502\u2013508. https:\/\/doi.org\/10.1016\/S0968-0004(00)01674-1","journal-title":"Trends Biochem Sci"},{"key":"1116_CR23","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/EURHEARTJ\/EHW148","volume":"37","author":"R Laaksonen","year":"2016","unstructured":"Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D, Suoniemi M, Hurme R, M\u00e4rz W, Scharnagl H, Stojakovic T, Vlachopoulou E, Lokki ML, Nieminen MS, Klingenberg R, Matter CM, Hornemann T, J\u00fcni P, Rodondi N, R\u00e4ber L, Windecker S, Gencer B, Pedersen ER, Tell GS, Nyg\u00e5rd O, Mach F, Sinisalo J, L\u00fcscher TF (2016) Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J 37:1967\u20131976. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHW148","journal-title":"Eur Heart J"},{"key":"1116_CR24","doi-asserted-by":"publisher","first-page":"11682","DOI":"10.3390\/IJMS222111682","volume":"22","author":"LV Boldyreva","year":"2021","unstructured":"Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN (2021) Fat of the gut: epithelial phospholipids in inflammatory bowel diseases. Int J Mol Sci 22:11682. https:\/\/doi.org\/10.3390\/IJMS222111682","journal-title":"Int J Mol Sci"},{"key":"1116_CR25","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/J.BBAMEM.2006.05.024","volume":"1758","author":"B S\u00e9gui","year":"2006","unstructured":"S\u00e9gui B, Andrieu-Abadie N, Jaffr\u00e9zou JP, Benoist H, Levade T (2006) Sphingolipids as modulators of cancer cell death: potential therapeutic targets. Biochim Biophys Acta 1758:2104\u20132120. https:\/\/doi.org\/10.1016\/J.BBAMEM.2006.05.024","journal-title":"Biochim Biophys Acta"},{"key":"1116_CR26","doi-asserted-by":"publisher","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R (2023) Gut-Microbiota-Derived metabolites maintain gut and systemic immune homeostasis. Cells 12. https:\/\/doi.org\/10.3390\/CELLS12050793","DOI":"10.3390\/CELLS12050793"},{"key":"1116_CR27","doi-asserted-by":"publisher","unstructured":"Chidambaram SB, Rathipriya AG, Mahalakshmi AM, Sharma S, Hediyal TA, Ray B, Sunanda T, Rungratanawanich W, Kashyap RS, Qoronfleh MW, Essa MM, Song BJ, Monaghan TM (2022) The influence of gut dysbiosis in the pathogenesis and management of ischemic stroke. Cells 11. https:\/\/doi.org\/10.3390\/CELLS11071239","DOI":"10.3390\/CELLS11071239"},{"key":"1116_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/S11306-019-1596-0","volume":"15","author":"BD Kayser","year":"2019","unstructured":"Kayser BD, Prifti E, Lhomme M, Belda E, Dao MC, Aron-Wisnewsky J, Cotillard A, Kennedy SP, Pons N, Le Chatelier E, Almeida M, Quinquis B, Galleron N, Batto JM, Renault P, Ehrlich SD, Blotti\u00e8re H, Leclerc M, de Wouters T, Lepage P, Dor\u00e9 J, Kontush A, Zucker JD, Rizkalla SW, Dugail I, Cl\u00e9ment K (2019) Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism. Metabolomics 15:140. https:\/\/doi.org\/10.1007\/S11306-019-1596-0","journal-title":"Metabolomics"},{"key":"1116_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/GUTJNL-2023-330009","volume":"73","author":"X Ma","year":"2024","unstructured":"Ma X, Zhang B, Xuan D, Li N, Yin L, Ning YL, Zhou Y, Yan T, Tong X, Zhu X, Huang M, Hu Z, Wang Z, Cui H, Li J, Wang JY, Fang R, Liu H, Chen J, Hong (2024) Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis. Gut 73:268\u2013281. https:\/\/doi.org\/10.1136\/GUTJNL-2023-330009","journal-title":"Gut"},{"key":"1116_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1568026620666200131094445","volume":"20","author":"G Anderson","year":"2020","unstructured":"Anderson G, Maes M (2020) Gut dysbiosis dysregulates central and systemic homeostasis via suboptimal mitochondrial function: assessment, treatment and classification implications. Curr Top Med Chem 20:524\u2013539. https:\/\/doi.org\/10.2174\/1568026620666200131094445","journal-title":"Curr Top Med Chem"},{"key":"1116_CR31","doi-asserted-by":"publisher","unstructured":"Rohrhofer J, Zwirzitz B, Selberherr E, Untersmayr E (2021) The impact of dietary sphingolipids on intestinal microbiota and Gastrointestinal immune homeostasis. Front Immunol 12. https:\/\/doi.org\/10.3389\/FIMMU.2021.635704","DOI":"10.3389\/FIMMU.2021.635704"},{"key":"1116_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","volume":"151","author":"FJ Gonzalez","year":"2016","unstructured":"Gonzalez FJ, Jiang C, Patterson AD (2016) An intestinal Microbiota\u2013Farnesoid X receptor axis modulates metabolic disease. Gastroenterology 151:845\u2013859. https:\/\/doi.org\/10.1053\/j.gastro.2016.08.057","journal-title":"Gastroenterology"},{"key":"1116_CR33","doi-asserted-by":"publisher","unstructured":"Jiang C, Xie C, Lv Y, Li J, Krausz KW, Shi J, Brocker CN, Desai D, Amin SG, Bisson WH, Liu Y, Gavrilova O, Patterson AD, Gonzalez FJ (2015) Intestine-selective farnesoid X receptor Inhibition improves obesity-related metabolic dysfunction. Nat Commun 6. https:\/\/doi.org\/10.1038\/NCOMMS10166","DOI":"10.1038\/NCOMMS10166"},{"key":"1116_CR34","doi-asserted-by":"publisher","unstructured":"Kim E, Jeon S (2023) The impact of phytochemicals in Obesity-Related metabolic diseases: focus on ceramide metabolism. Nutrients 15. https:\/\/doi.org\/10.3390\/NU15030703","DOI":"10.3390\/NU15030703"},{"key":"1116_CR35","doi-asserted-by":"publisher","unstructured":"Zhu Y, Gu L, Lin X, Zhang J, Tang Y, Zhou X, Lu B, Lin X, Liu C, Prochownik EV, Li Y (2022) Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice. JCI Insight 7. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.150607","DOI":"10.1172\/JCI.INSIGHT.150607"},{"key":"1116_CR36","doi-asserted-by":"publisher","unstructured":"Johnson EL, Heaver SL, Waters JL, Kim BI, Bretin A, Goodman AL, Gewirtz AT, Worgall TS, Ley RE (2020) Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. Nat Commun 11. https:\/\/doi.org\/10.1038\/S41467-020-16274-W","DOI":"10.1038\/S41467-020-16274-W"},{"key":"1116_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/J.MIB.2017.12.011","volume":"43","author":"SL Heaver","year":"2018","unstructured":"Heaver SL, Johnson EL, Ley RE (2018) Sphingolipids in host-microbial interactions. Curr Opin Microbiol 43:92\u201399. https:\/\/doi.org\/10.1016\/J.MIB.2017.12.011","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"1116_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, Li J (2022) Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Therapy 2022 7(7):1. https:\/\/doi.org\/10.1038\/s41392-022-01251-0","journal-title":"Signal Transduct Target Therapy 2022"},{"issue":"5","key":"1116_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s42255-023-00880-1","volume":"5","author":"D Hornburg","year":"2023","unstructured":"Hornburg D, Wu S, Moqri M, Zhou X, Contrepois K, Bararpour N, Traber GM, Su B, Metwally AA, Avina M, Zhou W, Ubellacker JM, Mishra T, Sch\u00fcssler-Fiorenza SM, Rose PB, Kavathas KJ, Williams MP, Snyder (2023) Dynamic lipidome alterations associated with human health, disease and ageing. Nat Metabolism 2023 5(5):9. https:\/\/doi.org\/10.1038\/s42255-023-00880-1","journal-title":"Nat Metabolism 2023"},{"key":"1116_CR40","doi-asserted-by":"publisher","unstructured":"Varela YR, Iriondo MN, Go\u00f1i FM, Alonso A, Montes LR (2024) Ceramide regulation of autophagy: A biophysical approach, biochimica et biophysica acta (BBA) - Molecular and cell biology of lipids. 1869:159444. https:\/\/doi.org\/10.1016\/J.BBALIP.2023.159444","DOI":"10.1016\/J.BBALIP.2023.159444"},{"key":"1116_CR41","doi-asserted-by":"publisher","unstructured":"Johnson AA, Stolzing A (2019) The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell 18. https:\/\/doi.org\/10.1111\/ACEL.13048","DOI":"10.1111\/ACEL.13048"},{"key":"1116_CR42","doi-asserted-by":"publisher","unstructured":"Huang X, Liu J, Dickson RC (2012) Down-regulating sphingolipid synthesis increases yeast lifespan. PLoS Genet 8. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1002493","DOI":"10.1371\/JOURNAL.PGEN.1002493"},{"key":"1116_CR43","doi-asserted-by":"publisher","unstructured":"Deng Z, Wang Q, Ding R, Nie W, Chen X, Chen Y, Wang Y, Duan J, Hu Z (2025) Loss of SUR2 alters the composition of ceramides and shortens chronological lifespan of Saccharomyces cerevisiae, biochimica et biophysica acta (BBA) - Molecular and cell biology of lipids 1870. 159591. https:\/\/doi.org\/10.1016\/J.BBALIP.2024.159591","DOI":"10.1016\/J.BBALIP.2024.159591"},{"key":"1116_CR44","doi-asserted-by":"publisher","unstructured":"Cutler RG, Thompson KW, Camandola S, Mack KT, Mattson MP (2014) Sphingolipid metabolism regulates development and lifespan in caenorhabditis elegans. Mech Ageing Dev 143\u2013144. https:\/\/doi.org\/10.1016\/J.MAD.2014.11.002","DOI":"10.1016\/J.MAD.2014.11.002"},{"key":"1116_CR45","doi-asserted-by":"publisher","unstructured":"Mosbech MB, Kruse R, Harvald EB, Olsen ASB, Gallego SF, Hannibal-Bach HK, Ejsing CS, F\u00e6rgeman NJ (2013) Functional loss of two ceramide synthases elicits autophagy-dependent lifespan extension in C. elegans. PLoS ONE 8. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0070087","DOI":"10.1371\/JOURNAL.PONE.0070087"},{"key":"1116_CR46","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1021\/ACSCHEMBIO.2C00216","volume":"17","author":"L Millner","year":"2022","unstructured":"Millner L, Running N, Colon-Rosa DS, Aga J, Frasor GE, Atilla-Gokcumen (2022) Ceramide-1-Phosphate is involved in Therapy-Induced senescence. ACS Chem Biol 17:822\u2013828. https:\/\/doi.org\/10.1021\/ACSCHEMBIO.2C00216","journal-title":"ACS Chem Biol"},{"key":"1116_CR47","doi-asserted-by":"publisher","unstructured":"Chen Q, Kovilakath A, Allegood J, Thompson J, Hu Y, Cowart LA, Lesnefsky EJ (2023) Endoplasmic reticulum stress and mitochondrial dysfunction during aging: role of sphingolipids. Biochim Biophys Acta Mol Cell Biol Lipids 1868. https:\/\/doi.org\/10.1016\/J.BBALIP.2023.159366","DOI":"10.1016\/J.BBALIP.2023.159366"},{"key":"1116_CR48","doi-asserted-by":"publisher","unstructured":"Pan Y, Li J, Lin P, Wan L, Qu Y, Cao L, Wang L (2024) A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, alzheimer\u2019s disease, and their co-morbidities. Front Pharmacol 15. https:\/\/doi.org\/10.3389\/FPHAR.2024.1348410","DOI":"10.3389\/FPHAR.2024.1348410"},{"key":"1116_CR49","doi-asserted-by":"publisher","unstructured":"Hady HR, B\u0142achnio-zabielska AU, Szczerbi\u0144ski \u0141, Zabielski P, Imierska M, Dadan J, Kr\u0119towski AJ (2019) Ceramide content in liver increases along with insulin resistance in obese patients. J Clin Med 8. https:\/\/doi.org\/10.3390\/JCM8122197","DOI":"10.3390\/JCM8122197"},{"key":"1116_CR50","doi-asserted-by":"publisher","first-page":"11364","DOI":"10.1073\/PNAS.0705049104","volume":"104","author":"RP Rao","year":"2007","unstructured":"Rao RP, Yuan C, Allegood JC, Rawat SS, Edwards MB, Wang X, Merrill AH, Acharya U, Acharya JK (2007) Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc Natl Acad Sci U S A 104:11364\u201311369. https:\/\/doi.org\/10.1073\/PNAS.0705049104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1116_CR51","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/S00018-010-0260-7","volume":"67","author":"Q Yang","year":"2010","unstructured":"Yang Q, Gong ZJ, Zhou Y, Yuan JQ, Cheng J, Tian L, Li S, Da Lin X, Xu R, Zhu ZR, Mao C (2010) Role of drosophila alkaline ceramidase (Dacer) in drosophila development and longevity. Cell Mol Life Sci 67:1477\u20131490. https:\/\/doi.org\/10.1007\/S00018-010-0260-7","journal-title":"Cell Mol Life Sci"},{"key":"1116_CR52","doi-asserted-by":"publisher","unstructured":"Mandal N, Grambergs R, Mondal K, Basu SK, Tahia F, Dagogo-Jack S (2021) Role of ceramides in the pathogenesis of diabetes mellitus and its complications. J Diabetes Complications 35. https:\/\/doi.org\/10.1016\/J.JDIACOMP.2020.107734","DOI":"10.1016\/J.JDIACOMP.2020.107734"},{"key":"1116_CR53","doi-asserted-by":"publisher","unstructured":"El-Amouri S, Karakashian A, Bieberich E, Nikolova-Karakashian M (2023) Regulated translocation of neutral sphingomyelinase-2 to the plasma membrane drives insulin resistance in steatotic hepatocytes. J Lipid Res 64. https:\/\/doi.org\/10.1016\/J.JLR.2023.100435","DOI":"10.1016\/J.JLR.2023.100435"},{"key":"1116_CR54","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/JN\/NXZ259","volume":"150","author":"AM Fretts","year":"2020","unstructured":"Fretts AM, Jensen PN, Hoofnagle A, McKnight B, Howard BV, Umans J, Yu C, Sitlani C, Siscovick DS, King IB, Sotoodehnia N, Lemaitre RN (2020) Plasma ceramide species are associated with diabetes risk in participants of the strong heart study. J Nutr 150:1214\u20131222. https:\/\/doi.org\/10.1093\/JN\/NXZ259","journal-title":"J Nutr"},{"key":"1116_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/S00125-021-05596-Z","volume":"65","author":"T Sarabhai","year":"2022","unstructured":"Sarabhai T, Koliaki C, Mastrototaro L, Kahl S, Pesta D, Apostolopoulou M, Wolkersdorfer M, B\u00f6nner AC, Bobrov P, Markgraf DF, Herder C, Roden M (2022) Dietary palmitate and oleate differently modulate insulin sensitivity in human skeletal muscle. Diabetologia 65:301\u2013314. https:\/\/doi.org\/10.1007\/S00125-021-05596-Z","journal-title":"Diabetologia"},{"key":"1116_CR56","doi-asserted-by":"publisher","unstructured":"Olson E, Suh JH, Schwarz JM, Noworolski SM, Jones GM, Barber JR, Erkin-Cakmak A, Mulligan K, Lustig RH, Mietus-Snyder M (2022) Effects of isocaloric Fructose restriction on ceramide levels in children with obesity and cardiometabolic risk: relation to hepatic de Novo lipogenesis and insulin sensitivity. Nutrients 14. https:\/\/doi.org\/10.3390\/NU14071432","DOI":"10.3390\/NU14071432"},{"key":"1116_CR57","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/J.CLNU.2023.12.008","volume":"43","author":"J Wang","year":"2024","unstructured":"Wang J, Wang D, Lu S, Hu Y, Ge Y, Qin X, Mo Y, Kan J, Li D, Zhang R, Liu Y, Zhang WS (2024) Ceramide enhanced the hepatic glucagon response through regulation of CREB activity. Clin Nutr 43:366\u2013378. https:\/\/doi.org\/10.1016\/J.CLNU.2023.12.008","journal-title":"Clin Nutr"},{"key":"1116_CR58","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/S00467-023-06257-6","volume":"39","author":"EJ Nehus","year":"2024","unstructured":"Nehus EJ, Sheanon NM, Zhang W, Marcovina SM, Setchell KDR, Mitsnefes MM (2024) Urinary sphingolipids in adolescents and young adults with youth-onset diabetes. Pediatr Nephrol 39:1875\u20131883. https:\/\/doi.org\/10.1007\/S00467-023-06257-6","journal-title":"Pediatr Nephrol"},{"key":"1116_CR59","doi-asserted-by":"publisher","unstructured":"Dagogo-Jack S, Asuzu P, Wan J, Grambergs R, Stentz F, Mandal N (2024) Plasma ceramides and other sphingolipids in relation to incident prediabetes in a longitudinal biracial cohort. J Clin Endocrinol Metab 109. https:\/\/doi.org\/10.1210\/CLINEM\/DGAE179","DOI":"10.1210\/CLINEM\/DGAE179"},{"key":"1116_CR60","doi-asserted-by":"publisher","unstructured":"Denimal D, Duvillard L, B\u00e9land-Bonenfant S, Terriat B, Pais-de-Barros JP, Simoneau I, Rouland A, Houbachi L, Bouillet B, Verg\u00e8s B, Petit JM (2024) Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes. Diabetes Metab 50. https:\/\/doi.org\/10.1016\/J.DIABET.2024.101542","DOI":"10.1016\/J.DIABET.2024.101542"},{"key":"1116_CR61","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/J.NUMECD.2023.10.026","volume":"34","author":"JC Bae","year":"2024","unstructured":"Bae JC, Wander PL, Lemaitre RN, Fretts AM, Sitlani CM, Bui HH, Thomas MK, Leonetti D, Fujimoto WY, Boyko EJ, Utzschneider KM (2024) Associations of plasma sphingolipids with measures of insulin sensitivity, \u03b2-cell function, and incident diabetes in Japanese Americans. Nutr Metab Cardiovasc Dis 34:633\u2013641. https:\/\/doi.org\/10.1016\/J.NUMECD.2023.10.026","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1116_CR62","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/J.JACC.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA (2022) The global burden of cardiovascular diseases and risk: A compass for future health. J Am Coll Cardiol 80:2361\u20132371. https:\/\/doi.org\/10.1016\/J.JACC.2022.11.005","journal-title":"J Am Coll Cardiol"},{"key":"1116_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.ATHEROSCLEROSIS.2021.04.021","volume":"327","author":"KA McGurk","year":"2021","unstructured":"McGurk KA, Keavney BD, Nicolaou A (2021) Circulating ceramides as biomarkers of cardiovascular disease: evidence from phenotypic and genomic studies. Atherosclerosis 327:18\u201330. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2021.04.021","journal-title":"Atherosclerosis"},{"key":"1116_CR64","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/EURHEARTJ\/EHZ387","volume":"41","author":"M Hilvo","year":"2020","unstructured":"Hilvo M, Meikle PJ, Pedersen ER, Tell GS, Dhar I, Brenner H, Sch\u00f6ttker B, L\u00e4\u00e4peri M, Kauhanen D, Koistinen KM, Jylh\u00e4 A, Huynh K, Mellett NA, Tonkin AM, Sullivan DR, Simes J, Nestel P, Koenig W, Rothenbacher D, Nyg\u00e5rd O, Laaksonen R (2020) Development and validation of a ceramide- and phospholipid-based cardiovascular risk Estimation score for coronary artery disease patients. Eur Heart J 41:371\u2013380. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHZ387","journal-title":"Eur Heart J"},{"key":"1116_CR65","doi-asserted-by":"publisher","unstructured":"Jensen PN, Fretts AM, Hoofnagle AN, McKnight B, Howard BV, Umans JG, Sitlani CM, Siscovick DS, King IB, Sotoodehnia N, Lemaitre RN (2022) Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study. Cardiovasc Diabetol 21. https:\/\/doi.org\/10.1186\/S12933-022-01596-4","DOI":"10.1186\/S12933-022-01596-4"},{"key":"1116_CR66","doi-asserted-by":"publisher","first-page":"E2343854","DOI":"10.1001\/JAMANETWORKOPEN.2023.43854","volume":"6","author":"LB Bockus","year":"2023","unstructured":"Bockus LB, Jensen PN, Fretts AM, Hoofnagle AN, McKnight B, Sitlani CM, Siscovick DS, King IB, Psaty BM, Sotoodehnia N, Lemaitre RN (2023) Plasma ceramides and sphingomyelins and sudden cardiac death in the cardiovascular health study. JAMA Netw Open 6:E2343854. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2023.43854","journal-title":"JAMA Netw Open"},{"key":"1116_CR67","doi-asserted-by":"publisher","unstructured":"Di Pietro P, Izzo C, Abate AC, Iesu P, Rusciano MR, Venturini E, Visco V, Sommella E, Ciccarelli M, Carrizzo A, Vecchione C (2023) The dark side of sphingolipids: searching for potential cardiovascular biomarkers. Biomolecules 13. https:\/\/doi.org\/10.3390\/BIOM13010168","DOI":"10.3390\/BIOM13010168"},{"key":"1116_CR68","doi-asserted-by":"publisher","unstructured":"Arosio B, Corbi G, Davinelli S, Giordano V, Liccardo D, Rapacciuolo A, Cannavo A (2022) Sex differences in cardiovascular diseases: A matter of estrogens, ceramides, and sphingosine 1-Phosphate. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/IJMS23074009","DOI":"10.3390\/IJMS23074009"},{"key":"1116_CR69","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","volume":"141","author":"Y Hadas","year":"2020","unstructured":"Hadas Y, Vincek AS, Youssef E, \u017bak MM, Chepurko E, Sultana N, Sharkar MTK, Guo N, Komargodski R, Kurian AA, Kaur K, Magadum A, Fargnoli A, Katz MG, Hossain N, Kenigsberg E, Dubois NC, Schadt E, Hajjar R, Eliyahu E, Zangi L (2020) Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction. Circulation 141:916\u2013930. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041882","journal-title":"Circulation"},{"key":"1116_CR70","doi-asserted-by":"publisher","unstructured":"Ji R, Akashi H, Drosatos K, Liao X, Jiang H, Kennel PJ, Brunjes DL, Castillero E, Zhang X, Deng LY, Homma S, George IJ, Takayama H, Naka Y, Goldberg IJ, Schulze PC (2017) Increased de Novo ceramide synthesis and accumulation in failing myocardium. JCI Insight 2. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.82922","DOI":"10.1172\/JCI.INSIGHT.82922"},{"key":"1116_CR71","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/S41569-021-00536-1","volume":"18","author":"RH Choi","year":"2021","unstructured":"Choi RH, Tatum SM, Symons JD, Summers SA, Holland WL (2021) Ceramides and other sphingolipids as drivers of cardiovascular disease. Nat Rev Cardiol 18:701\u2013711. https:\/\/doi.org\/10.1038\/S41569-021-00536-1","journal-title":"Nat Rev Cardiol"},{"key":"1116_CR72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.FREERADBIOMED.2021.02.016","volume":"167","author":"M Bekhite","year":"2021","unstructured":"Bekhite M, Gonz\u00e1lez-Delgado A, H\u00fcbner S, Haxhikadrija P, Kretzschmar T, M\u00fcller T, Wu JMF, Bekfani T, Franz M, Wartenberg M, Gr\u00e4ler M, Greber B, Schulze PC (2021) The role of ceramide accumulation in human induced pluripotent stem cell-derived cardiomyocytes on mitochondrial oxidative stress and mitophagy. Free Radic Biol Med 167:66\u201380. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2021.02.016","journal-title":"Free Radic Biol Med"},{"key":"1116_CR73","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1096\/FJ.201700300R","volume":"32","author":"BA Law","year":"2018","unstructured":"Law BA, Liao X, Moore KS, Southard A, Roddy P, Ji R, Szulc Z, Bielawska A, Schulze PC, Cowart LA (2018) Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes. FASEB J 32:1403\u20131416. https:\/\/doi.org\/10.1096\/FJ.201700300R","journal-title":"FASEB J"},{"key":"1116_CR74","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/MOL.0000000000000802","volume":"33","author":"LK Park","year":"2022","unstructured":"Park LK, Barry VG, Hong J, Heebink J, Sah R, Peterson LR (2022) Links between ceramides and cardiac function. Curr Opin Lipidol 33:47\u201356. https:\/\/doi.org\/10.1097\/MOL.0000000000000802","journal-title":"Curr Opin Lipidol"},{"key":"1116_CR75","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/J.BBADIS.2013.04.009","volume":"1832","author":"V Parra","year":"2013","unstructured":"Parra V, Moraga F, Kuzmicic J, L\u00f3pez-Crisosto C, Troncoso R, Torrealba N, Criollo A, D\u00edaz-Elizondo J, Rothermel BA, Quest AFG, Lavandero S (2013) Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death. Biochim Biophys Acta 1832:1334\u20131344. https:\/\/doi.org\/10.1016\/J.BBADIS.2013.04.009","journal-title":"Biochim Biophys Acta"},{"key":"1116_CR76","doi-asserted-by":"publisher","unstructured":"Chaurasia B, Talbot CL, Summers SA (2020) Adipocyte Ceramides-The nexus of inflammation and metabolic disease. Front Immunol 11. https:\/\/doi.org\/10.3389\/FIMMU.2020.576347","DOI":"10.3389\/FIMMU.2020.576347"},{"key":"1116_CR77","doi-asserted-by":"publisher","first-page":"232","DOI":"10.14336\/AD.2021.0710","volume":"13","author":"H Shu","year":"2022","unstructured":"Shu H, Peng Y, Hang W, Li N, Zhou N, Wang DW (2022) Emerging roles of ceramide in cardiovascular diseases. Aging Dis 13:232\u2013245. https:\/\/doi.org\/10.14336\/AD.2021.0710","journal-title":"Aging Dis"},{"key":"1116_CR78","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/ATVBAHA.118.311208","volume":"38","author":"T Lallemand","year":"2018","unstructured":"Lallemand T, Rouahi M, Swiader A, Grazide MH, Geoffre N, Alayrac P, Recazens E, Coste A, Salvayre R, N\u00e8gre-Salvayre A, Aug\u00e9 N (2018) nSMase2 (Type 2-Neutral Sphingomyelinase) deficiency or Inhibition by GW4869 reduces inflammation and atherosclerosis in Apoe-\/- mice. Arterioscler Thromb Vasc Biol 38:1479\u20131492. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311208","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1116_CR79","doi-asserted-by":"publisher","unstructured":"Cogolludo E, Villamor F, Perez-Vizcaino L, Moreno (2019) Ceramide and regulation of vascular tone. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/IJMS20020411","DOI":"10.3390\/IJMS20020411"},{"key":"1116_CR80","doi-asserted-by":"publisher","unstructured":"Reforgiato MR, Milano G, Fabri\u00e0s G, Casas J, Gasco P, Paroni R, Samaja M, Ghidoni R, Caretti A, Signorelli P (2016) Inhibition of ceramide de Novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury. Basic Res Cardiol 111. https:\/\/doi.org\/10.1007\/S00395-016-0533-X","DOI":"10.1007\/S00395-016-0533-X"},{"key":"1116_CR81","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/J.CELREP.2018.02.034","volume":"22","author":"SM Walls","year":"2018","unstructured":"Walls SM, Cammarato A, Chatfield DA, Ocorr K, Harris GL, Bodmer R (2018) Ceramide-Protein interactions modulate Ceramide-Associated lipotoxic cardiomyopathy. Cell Rep 22:2702\u20132715. https:\/\/doi.org\/10.1016\/J.CELREP.2018.02.034","journal-title":"Cell Rep"},{"key":"1116_CR82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/J.ATHEROSCLEROSIS.2020.04.008","volume":"302","author":"W Pan","year":"2020","unstructured":"Pan W, Sun M, Wu J, Dong H, Liu J, Gao R, Fang S, Xing L, Hu S, Yu B (2020) Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction. Atherosclerosis 302:8\u201314. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2020.04.008","journal-title":"Atherosclerosis"},{"key":"1116_CR83","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/S12265-020-09978-3","volume":"14","author":"W Pan","year":"2021","unstructured":"Pan W, Dong H, Sun R, Zhao L, Sun M, Li L, Yu X, Liu J, Wu J, Yang F, Yu B (2021) Plasma ceramides in relation to coronary plaque characterization determined by optical coherence tomography. J Cardiovasc Transl Res 14:140\u2013149. https:\/\/doi.org\/10.1007\/S12265-020-09978-3","journal-title":"J Cardiovasc Transl Res"},{"key":"1116_CR84","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/J.JACC.2021.03.314","volume":"77","author":"N Akawi","year":"2021","unstructured":"Akawi N, Checa A, Antonopoulos AS, Akoumianakis I, Daskalaki E, Kotanidis CP, Kondo H, Lee K, Yesilyurt D, Badi I, Polkinghorne M, Akbar N, Lundgren J, Chuaiphichai S, Choudhury R, Neubauer S, Channon KM, Torekov SS, Wheelock CE, Antoniades C (2021) Fat-Secreted ceramides regulate vascular redox state and influence outcomes in patients with cardiovascular disease. J Am Coll Cardiol 77:2494\u20132513. https:\/\/doi.org\/10.1016\/J.JACC.2021.03.314","journal-title":"J Am Coll Cardiol"},{"key":"1116_CR85","doi-asserted-by":"publisher","unstructured":"Juchnicka M, Ku\u017amicki J, Szamatowicz (2021) Ceramides and Sphingosino-1-Phosphate in obesity. Front Endocrinol (Lausanne) 12. https:\/\/doi.org\/10.3389\/FENDO.2021.635995","DOI":"10.3389\/FENDO.2021.635995"},{"key":"1116_CR86","doi-asserted-by":"publisher","unstructured":"Hammerschmidt P, Br\u00fcning JC (2022) Contribution of specific ceramides to obesity-associated metabolic diseases. Cell Mol Life Sci 79. https:\/\/doi.org\/10.1007\/S00018-022-04401-3","DOI":"10.1007\/S00018-022-04401-3"},{"key":"1116_CR87","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.cmet.2016.10.002","volume":"24","author":"B Chaurasia","year":"2016","unstructured":"Chaurasia B, Kaddai VA, Lancaster GI, Henstridge DC, Sriram S, Galam DLA, Gopalan V, Prakash KNB, Velan SS, Bulchand S, Tsong TJ, Wang M, Siddique MM, Yuguang G, Sigmundsson K, Mellet NA, Weir JM, Meikle PJ, Bin MS, Yassin M, Shabbir A, Shayman JA, Hirabayashi Y, Shiow SATE, Sugii S (2016) Summers, adipocyte ceramides regulate subcutaneous adipose browning, inflammation, and metabolism. Cell Metab 24:820\u2013834. https:\/\/doi.org\/10.1016\/j.cmet.2016.10.002","journal-title":"Cell Metab"},{"key":"1116_CR88","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/OBY.22405","volume":"27","author":"B Choroma\u0144ska","year":"2019","unstructured":"Choroma\u0144ska B, My\u015bliwiec P, Razak Hady H, Dadan J, My\u015bliwiec H, Chabowski A, Mik\u0142osz A (2019) Metabolic syndrome is associated with ceramide accumulation in visceral adipose tissue of women with morbid obesity. Obes (Silver Spring) 27:444\u2013453. https:\/\/doi.org\/10.1002\/OBY.22405","journal-title":"Obes (Silver Spring)"},{"key":"1116_CR89","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/LIPD.12367","volume":"58","author":"KA Lytle","year":"2023","unstructured":"Lytle KA, Chung JO, Bush NC, Triay JM, Jensen MD (2023) Ceramide concentrations in liver, plasma, and very low-density lipoproteins of humans with severe obesity. Lipids 58:107\u2013115. https:\/\/doi.org\/10.1002\/LIPD.12367","journal-title":"Lipids"},{"key":"1116_CR90","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1111\/ALL.14366","volume":"75","author":"Y Choi","year":"2020","unstructured":"Choi Y, Kim M, Kim SJ, Yoo HJ, Kim SH, Park HS (2020) Metabolic shift favoring C18:0 ceramide accumulation in obese asthma. Allergy 75:2858\u20132866. https:\/\/doi.org\/10.1111\/ALL.14366","journal-title":"Allergy"},{"key":"1116_CR91","doi-asserted-by":"publisher","unstructured":"Li Y, Talbot CL, Chaurasia B (2020) Ceramides in adipose tissue. Front Endocrinol (Lausanne) 11. https:\/\/doi.org\/10.3389\/FENDO.2020.00407","DOI":"10.3389\/FENDO.2020.00407"},{"key":"1116_CR92","doi-asserted-by":"publisher","unstructured":"Kojta M, Chaci\u0144ska A, B\u0142achnio-Zabielska (2020) Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients 12. https:\/\/doi.org\/10.3390\/NU12051305","DOI":"10.3390\/NU12051305"},{"key":"1116_CR93","doi-asserted-by":"publisher","unstructured":"Reginato ACC, Veras MdaN, Baqueiro C, Panzarin BP, Siqueira M, Milanski PC, Lisboa AS, Torsoni (2021) The role of fatty acids in ceramide pathways and their influence on hypothalamic regulation of energy balance: A systematic review. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/IJMS22105357","DOI":"10.3390\/IJMS22105357"},{"key":"1116_CR94","doi-asserted-by":"publisher","unstructured":"Magnan H, Le Stunff (2021) Role of hypothalamic de Novo ceramides synthesis in obesity and associated metabolic disorders. Mol Metab 53. https:\/\/doi.org\/10.1016\/J.MOLMET.2021.101298","DOI":"10.1016\/J.MOLMET.2021.101298"},{"key":"1116_CR95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2337\/DB15-1547","volume":"66","author":"I Contreras","year":"2017","unstructured":"Contreras I, Gonz\u00e1lez-Garc\u00eda P, Seoane-Collazo N, Mart\u00ednez-S\u00e1nchez L, Li\u00f1ares-Pose E, Rial-Pensado J, Fern\u00f8 M, Tena-Sempere N, Casals C, Di\u00e9guez R, Nogueiras M, L\u00f3pez (2017) Reduction of hypothalamic Endoplasmic reticulum stress activates Browning of white fat and ameliorates obesity. Diabetes 66:87\u201399. https:\/\/doi.org\/10.2337\/DB15-1547","journal-title":"Diabetes"},{"key":"1116_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/JCM10040792","volume":"10","author":"F Hajduch","year":"2021","unstructured":"Hajduch F, Lachkar P, Ferr\u00e9 F, Foufelle (2021) Roles of ceramides in Non-Alcoholic fatty liver disease. J Clin Med 10:1\u201319. https:\/\/doi.org\/10.3390\/JCM10040792","journal-title":"J Clin Med"},{"key":"1116_CR97","doi-asserted-by":"publisher","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, Singhal R, Mahawar K, Ramnarain D (2022) Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord 22. https:\/\/doi.org\/10.1186\/S12902-022-00980-1","DOI":"10.1186\/S12902-022-00980-1"},{"key":"1116_CR98","doi-asserted-by":"publisher","unstructured":"Pei T, Gui D, Kan H, Feng Y, Jin Y, Yang Q, Zhang Z, Du Z, Gai J, Wu Y, Li (2020) An overview of lipid metabolism and nonalcoholic fatty liver disease. Biomed Res Int 2020. https:\/\/doi.org\/10.1155\/2020\/4020249","DOI":"10.1155\/2020\/4020249"},{"key":"1116_CR99","doi-asserted-by":"publisher","unstructured":"B\u00e9land-Bonenfant S, Rouland A, Petit JM, Verg\u00e8s B (2023) Concise review of lipidomics in nonalcoholic fatty liver disease. Diabetes Metab 49. https:\/\/doi.org\/10.1016\/J.DIABET.2023.101432","DOI":"10.1016\/J.DIABET.2023.101432"},{"key":"1116_CR100","doi-asserted-by":"publisher","unstructured":"Paul B, Lewinska M, Andersen JB (2022) Lipid alterations in chronic liver disease and liver cancer. JHEP Rep 4. https:\/\/doi.org\/10.1016\/J.JHEPR.2022.100479","DOI":"10.1016\/J.JHEPR.2022.100479"},{"key":"1116_CR101","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/J.BBALIP.2019.02.004","volume":"1864","author":"IO Shmarakov","year":"2019","unstructured":"Shmarakov IO, Jiang H, Liu J, Fernandez EJ, Blaner WS (2019) Hepatic stellate cell activation: A source for bioactive lipids. Biochim Biophys Acta Mol Cell Biol Lipids 1864:629\u2013642. https:\/\/doi.org\/10.1016\/J.BBALIP.2019.02.004","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1116_CR102","doi-asserted-by":"publisher","unstructured":"Gadgil MD, Sarkar M, Sands C, Lewis MR, Herrington DM, Kanaya AM (2022) Associations of NAFLD with Circulating ceramides and impaired glycemia. Diabetes Res Clin Pract 186. https:\/\/doi.org\/10.1016\/J.DIABRES.2022.109829","DOI":"10.1016\/J.DIABRES.2022.109829"},{"key":"1116_CR103","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/HEP.31095","volume":"71","author":"H Yki-J\u00e4rvinen","year":"2020","unstructured":"Yki-J\u00e4rvinen H (2020) Ceramides: A cause of insulin resistance in nonalcoholic fatty liver disease in both murine models and humans. Hepatology 71:1499\u20131501. https:\/\/doi.org\/10.1002\/HEP.31095","journal-title":"Hepatology"},{"key":"1116_CR104","doi-asserted-by":"publisher","unstructured":"Tanase DM, Gosav EM, Petrov D, Jucan AE, Lacatusu CM, Floria M, Tarniceriu CC, Costea CF, Ciocoiu M, Rezus C, Targets (2021) Diagnostics (Basel) 11. https:\/\/doi.org\/10.3390\/DIAGNOSTICS11112053","DOI":"10.3390\/DIAGNOSTICS11112053"},{"key":"1116_CR105","doi-asserted-by":"publisher","unstructured":"Babiy B, Ramos-Molina B, Oca\u00f1a L, Sacrist\u00e1n S, Burgos-Santamar\u00eda D, Mart\u00ednez-Botas J, Busto R, Perna C, Frutos MD, Albillos A, Pastor \u00d3 (2023) Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease. Biochim Biophys Acta Mol Cell Biol Lipids 1868. https:\/\/doi.org\/10.1016\/J.BBALIP.2023.159318","DOI":"10.1016\/J.BBALIP.2023.159318"},{"key":"1116_CR106","doi-asserted-by":"publisher","unstructured":"Yu XD, Wang JW (2022) Ceramide de Novo synthesis in non-alcoholic fatty liver disease: pathogenic mechanisms and therapeutic perspectives. Biochem Pharmacol 202. https:\/\/doi.org\/10.1016\/J.BCP.2022.115157","DOI":"10.1016\/J.BCP.2022.115157"},{"key":"1116_CR107","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4254\/WJH.V12.I8.436","volume":"12","author":"S Kartsoli","year":"2020","unstructured":"Kartsoli S, Kostara CE, Tsimihodimos V, Bairaktari ET, Christodoulou DK (2020) Lipidomics in non-alcoholic fatty liver disease. World J Hepatol 12:436\u2013450. https:\/\/doi.org\/10.4254\/WJH.V12.I8.436","journal-title":"World J Hepatol"},{"key":"1116_CR108","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/IJBS.78525","volume":"19","author":"C Zhu","year":"2023","unstructured":"Zhu C, Huai Q, Zhang X, Dai H, Li X, Wang H (2023) Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease. Int J Biol Sci 19:311\u2013330. https:\/\/doi.org\/10.7150\/IJBS.78525","journal-title":"Int J Biol Sci"},{"key":"1116_CR109","doi-asserted-by":"publisher","first-page":"6989","DOI":"10.1074\/JBC.M115.691212","volume":"291","author":"D Gosejacob","year":"2016","unstructured":"Gosejacob D, J\u00e4ger PS, Vom Dorp K, Frejno M, Carstensen AC, K\u00f6hnke M, Degen J, D\u00f6rmann P, Hoch M (2016) Ceramide synthase 5 is essential to maintain C16:0-Ceramide pools and contributes to the development of Diet-induced obesity. J Biol Chem 291:6989\u20137003. https:\/\/doi.org\/10.1074\/JBC.M115.691212","journal-title":"J Biol Chem"},{"key":"1116_CR110","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/J.CMET.2014.08.002","volume":"20","author":"SM Turpin","year":"2014","unstructured":"Turpin SM, Nicholls HT, Willmes DM, Mourier A, Brodesser S, Wunderlich CM, Mauer J, Xu E, Hammerschmidt P, Br\u00f6nneke HS, Trifunovic A, Losasso G, Wunderlich FT, Kornfeld JW, Bl\u00fcher M, Kr\u00f6nke M, Br\u00fcning JC (2014) Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20:678\u2013686. https:\/\/doi.org\/10.1016\/J.CMET.2014.08.002","journal-title":"Cell Metab"},{"key":"1116_CR111","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MOL.0000000000000804","volume":"33","author":"LMI Loft","year":"2022","unstructured":"Loft LMI, Moseholm KF, Pedersen KKW, Jensen MK, Koch M, Cronj\u00e9 HT (2022) Sphingomyelins and ceramides: possible biomarkers for dementia? Curr Opin Lipidol 33:57\u201367. https:\/\/doi.org\/10.1097\/MOL.0000000000000804","journal-title":"Curr Opin Lipidol"},{"key":"1116_CR112","doi-asserted-by":"publisher","unstructured":"Rahimi S, Angaji SA, Majd A, Hatami B, Baghaei K (2023) Evaluating the effect of basic fibroblast growth factor on the progression of NASH disease by inhibiting ceramide synthesis and ER stress-related pathways. Eur J Pharmacol 942. https:\/\/doi.org\/10.1016\/J.EJPHAR.2023.175536","DOI":"10.1016\/J.EJPHAR.2023.175536"},{"key":"1116_CR113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.19852\/J.CNKI.JTCM.20231215.002","volume":"44","author":"S Yang","year":"2024","unstructured":"Yang S, Ma Y, Bai Z, Yu Y, Fang B, Zhang L, Wang L (2024) Intervention effect of Cigu Xiaozhi prescription on ceramide lipoapoptosis in non-alcoholic fatty liver disease. J Tradit Chin Med 44:63\u201369. https:\/\/doi.org\/10.19852\/J.CNKI.JTCM.20231215.002","journal-title":"J Tradit Chin Med"},{"key":"1116_CR114","doi-asserted-by":"publisher","unstructured":"Alessenko V, Albi E (2020) Exploring sphingolipid implications in neurodegeneration. Front Neurol 11. https:\/\/doi.org\/10.3389\/FNEUR.2020.00437","DOI":"10.3389\/FNEUR.2020.00437"},{"key":"1116_CR115","doi-asserted-by":"publisher","unstructured":"den Hoedt S, Crivelli SM, Leijten FPJ, Losen M, Stevens JAA, Man\u00e9-Damas M, de Vries HE, Walter J, Mirzaian M, Sijbrands EJG, Aerts JMFG, Verhoeven AJM, Martinez-Martinez P, Mulder MT (2021) Effects of sex, age, and Apolipoprotein E genotype on brain ceramides and Sphingosine-1-Phosphate in alzheimer\u2019s disease and control mice. Front Aging Neurosci 13. https:\/\/doi.org\/10.3389\/FNAGI.2021.765252","DOI":"10.3389\/FNAGI.2021.765252"},{"key":"1116_CR116","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3233\/JAD-215205","volume":"85","author":"M Kurano","year":"2022","unstructured":"Kurano M, Tsukamoto K, Sakai E, Hara M, Yatomi Y (2022) Isoform-Dependent effects of Apolipoprotein E on sphingolipid metabolism in neural cells. J Alzheimers Dis 85:1529\u20131544. https:\/\/doi.org\/10.3233\/JAD-215205","journal-title":"J Alzheimers Dis"},{"key":"1116_CR117","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/CHIR.23568","volume":"35","author":"M Abdelrasoul","year":"2023","unstructured":"Abdelrasoul M, Yuyama K, Swamy MMM, Murai Y, Monde K (2023) Stereochemistry-activity relationship of ceramide-induced exosome production to clear amyloid-\u03b2 in alzheimer\u2019s disease. Chirality 35:577\u2013585. https:\/\/doi.org\/10.1002\/CHIR.23568","journal-title":"Chirality"},{"key":"1116_CR118","doi-asserted-by":"publisher","unstructured":"Fan C, Tian Y, Zhang Y, Teng J, Zhao X (2022) Ceramide induces macrophage migration inhibitory factor -mediated parthanatos in mouse neurons by increasing ROS levels. Neurosci Lett 788. https:\/\/doi.org\/10.1016\/J.NEULET.2022.136862","DOI":"10.1016\/J.NEULET.2022.136862"},{"key":"1116_CR119","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/S00213-024-06530-Y","volume":"241","author":"X Liu","year":"2024","unstructured":"Liu X, Jin Y, Cheng X, Song Q, Wang Y, He L, Chen T (2024) The relevance between abnormally elevated serum ceramide and cognitive impairment in alzheimer\u2019s disease model mice and its mechanism. Psychopharmacology 241:525\u2013542. https:\/\/doi.org\/10.1007\/S00213-024-06530-Y","journal-title":"Psychopharmacology"},{"key":"1116_CR120","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/J.SJBS.2019.10.001","volume":"27","author":"NEA Gaboon","year":"2020","unstructured":"Gaboon NEA, Banaganapalli B, Nasser K, Razeeth M, Alsaedi MS, Rashidi OM, Abdelwehab LS, Alahmadi TS, Safdar OY, Shaik J, Choudhry HMZ, Al-numan HH, Khan MI, Al-Aama JY, Elango R, Shaik NA (2020) Exome sequencing and metabolomic analysis of a chronic kidney disease and hearing loss patient family revealed RMND1 mutation induced sphingolipid metabolism defects. Saudi J Biol Sci 27:324\u2013334. https:\/\/doi.org\/10.1016\/J.SJBS.2019.10.001","journal-title":"Saudi J Biol Sci"},{"key":"1116_CR121","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/S00467-013-2642-1","volume":"29","author":"M Mitsnefes","year":"2014","unstructured":"Mitsnefes M, Scherer PE, Friedman LA, Gordillo R, Furth S, Warady BA (2014) Ceramides and cardiac function in children with chronic kidney disease. Pediatr Nephrol 29:415\u2013422. https:\/\/doi.org\/10.1007\/S00467-013-2642-1","journal-title":"Pediatr Nephrol"},{"key":"1116_CR122","doi-asserted-by":"publisher","unstructured":"Lidgard B, Hoofnagle AN, Zelnick LR, de Boer IH, Fretts AM, Kestenbaum BR, Lemaitre RN, Robinson-Cohen C, Bansal N (2023) High-Density lipoprotein lipidomics and mortality in CKD. Kidney Med 5. https:\/\/doi.org\/10.1016\/J.XKME.2023.100708","DOI":"10.1016\/J.XKME.2023.100708"},{"key":"1116_CR123","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/J.EKIR.2016.12.003","volume":"2","author":"JJ Liu","year":"2016","unstructured":"Liu JJ, Ghosh S, Kovalik JP, Ching J, Choi HW, Tavintharan S, Ong CN, Sum CF, Summers SA, Tai ES, Lim SC (2016) Profiling of plasma metabolites suggests altered mitochondrial fuel usage and remodeling of sphingolipid metabolism in individuals with type 2 diabetes and kidney disease. Kidney Int Rep 2:470\u2013480. https:\/\/doi.org\/10.1016\/J.EKIR.2016.12.003","journal-title":"Kidney Int Rep"},{"key":"1116_CR124","doi-asserted-by":"publisher","unstructured":"D. Y MA (2020) Role of sphingolipid signaling in glomerular diseases: focus on DKD and FSGS. J Cell Signal 1. https:\/\/doi.org\/10.33696\/SIGNALING.1.013","DOI":"10.33696\/SIGNALING.1.013"},{"key":"1116_CR125","doi-asserted-by":"publisher","unstructured":"Mantovani G, Lunardi S, Bonapace C, Dugo A, Altomari G, Molon A, Conti C, Bovo R, Laaksonen CD, Byrne F, Bonnet G, Targher (2021) Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease. Diabetes Metab 47. https:\/\/doi.org\/10.1016\/J.DIABET.2020.03.003","DOI":"10.1016\/J.DIABET.2020.03.003"},{"key":"1116_CR126","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/J.TOXLET.2019.03.002","volume":"308","author":"F Savira","year":"2019","unstructured":"Savira F, Magaye R, Hua Y, Liew D, Kaye D, Marwick T, Wang BH (2019) Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy. Toxicol Lett 308:34\u201349. https:\/\/doi.org\/10.1016\/J.TOXLET.2019.03.002","journal-title":"Toxicol Lett"},{"key":"1116_CR127","doi-asserted-by":"publisher","unstructured":"Ahmed MSE, Abed M, Voelkl J, Lang F (2013) Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate. BMC Nephrol 14. https:\/\/doi.org\/10.1186\/1471-2369-14-244","DOI":"10.1186\/1471-2369-14-244"},{"key":"1116_CR128","doi-asserted-by":"publisher","unstructured":"Eckes T, Trautmann S, Djudjaj S, Beyer S, Patyna S, Schwalm S, Gauer S, Thomas D, Schaefer L, Boor P, Koch A, Pfeilschifter J (2021) Consistent alteration of chain length-specific ceramides in human and mouse fibrotic kidneys. Biochim Biophys Acta Mol Cell Biol Lipids 1866. https:\/\/doi.org\/10.1016\/J.BBALIP.2020.158821","DOI":"10.1016\/J.BBALIP.2020.158821"},{"key":"1116_CR129","doi-asserted-by":"publisher","unstructured":"Baccam GC, Xie J, Jin X, Park H, Wang B, Husson H, Ibraghimov-Beskrovnaya O, Huang CL (2022) Glucosylceramide synthase Inhibition protects against cardiac hypertrophy in chronic kidney disease. Sci Rep 12. https:\/\/doi.org\/10.1038\/S41598-022-13390-Z","DOI":"10.1038\/S41598-022-13390-Z"},{"key":"1116_CR130","doi-asserted-by":"publisher","unstructured":"Wang X, Yu H, Li D, He S, Zeng Z, Xiang (2023) Cell and rat serum, urine and tissue metabolomics analysis elucidates the key pathway changes associated with chronic nephropathy and reveals the mechanism of action of Rhein. Chin Med 18. https:\/\/doi.org\/10.1186\/S13020-023-00862-1","DOI":"10.1186\/S13020-023-00862-1"},{"key":"1116_CR131","doi-asserted-by":"publisher","unstructured":"Cena H (2020) P.C. Calder Defining a healthy diet: evidence for the role of contemporary dietary patterns in health and disease. Nutrients 12 https:\/\/doi.org\/10.3390\/NU12020334","DOI":"10.3390\/NU12020334"},{"key":"1116_CR132","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/10408398.2022.2107611","volume":"64","author":"D Mafra","year":"2024","unstructured":"Mafra D, Ugochukwu SA, Borges NA, Cardozo LFMF, Stenvinkel P, Shiels PG (2024) Food for healthier aging: power on your plate. Crit Rev Food Sci Nutr 64:603\u2013616. https:\/\/doi.org\/10.1080\/10408398.2022.2107611","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1116_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/METABO11020093","volume":"11","author":"JYH Seah","year":"2021","unstructured":"Seah JYH, Chew WS, Torta F, Khoo CM, Wenk MR, Herr DR, Shyong Tai E, van Dam RM (2021) Dietary fat and protein intake in relation to plasma sphingolipids as determined by a Large-Scale lipidomic analysis. Metabolites 11:1\u201313. https:\/\/doi.org\/10.3390\/METABO11020093","journal-title":"Metabolites"},{"key":"1116_CR134","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1194\/JLR.M001230","volume":"51","author":"R Harmancey","year":"2010","unstructured":"Harmancey R, Wilson CR, Wright NR, Taegtmeyer H (2010) Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis. J Lipid Res 51:1380\u20131393. https:\/\/doi.org\/10.1194\/JLR.M001230","journal-title":"J Lipid Res"},{"key":"1116_CR135","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/AJCN\/NQZ257","volume":"111","author":"ME Walker","year":"2020","unstructured":"Walker ME, Xanthakis V, Moore LL, Vasan RS, Jacques PF (2020) Cumulative sugar-sweetened beverage consumption is associated with higher concentrations of Circulating ceramides in the Framingham offspring cohort. Am J Clin Nutr 111:420\u2013428. https:\/\/doi.org\/10.1093\/AJCN\/NQZ257","journal-title":"Am J Clin Nutr"},{"key":"1116_CR136","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.2337\/DC18-0071","volume":"41","author":"PK Luukkonen","year":"2018","unstructured":"Luukkonen PK, S\u00e4devirta S, Zhou Y, Kayser B, Ali A, Ahonen L, Lallukka S, Pelloux V, Gaggini M, Jian C, Hakkarainen A, Lundbom N, Gylling H, Salonen A, Oresic M, Hy\u00f6tyl\u00e4inen T, Orho-Melander M, Rissanen A, Gastaldelli A, Cl\u00e9ment K, Hodson L (2018) Yki-J\u00e4rvinen, saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care 41:1732\u20131739. https:\/\/doi.org\/10.2337\/DC18-0071","journal-title":"Diabetes Care"},{"key":"1116_CR137","doi-asserted-by":"publisher","unstructured":"Mathews AT, Famodu OA, Olfert MD, Murray PJ, Cuff CF, Downes MT, Haughey NJ, Colby SE, Chantler PD, Olfert IM, McFadden JW (2017) Efficacy of nutritional interventions to lower Circulating ceramides in young adults: FRUVEDomic pilot study. Physiol Rep 5. https:\/\/doi.org\/10.14814\/PHY2.13329","DOI":"10.14814\/PHY2.13329"},{"key":"1116_CR138","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3945\/JN.115.220459","volume":"146","author":"U Lankinen","year":"2015","unstructured":"Lankinen U, Schwab M, Kolehmainen J, Paananen H, Nygren T, Sepp\u00e4nen-Laakso K, Poutanen T, Hy\u00f6tyl\u00e4inen U, Ris\u00e9rus MJ, Savolainen J, Hukkanen L, Brader M, Marklund F, Rosqvist K, Hermansen L, Cloetens G, \u00d6nning I, Thorsdottir I, Gunnarsdottir B, \u00c5kesson LO, Dragsted M, Uusitupa M, Ore\u0161i\u010d (2015) A healthy nordic diet alters the plasma lipidomic profile in adults with features of metabolic syndrome in a multicenter randomized dietary intervention. J Nutr 146:662\u2013672. https:\/\/doi.org\/10.3945\/JN.115.220459","journal-title":"J Nutr"},{"key":"1116_CR139","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/J.DIABET.2019.06.002","volume":"46","author":"F Fumeron","year":"2020","unstructured":"Fumeron F, Nicolas A, Bastard JP, Fellahi S, Wigger L, Ibberson M, Cruciani-Guglielmacci C, Le Stunff H, Velho G, Magnan C, Marre M, Balkau B, Roussel R (2020) Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. Cohort. Diabetes Metab 46:144\u2013149. https:\/\/doi.org\/10.1016\/J.DIABET.2019.06.002","journal-title":"Diabetes Metab"},{"key":"1116_CR140","doi-asserted-by":"publisher","unstructured":"Li J, Xie S, Teng W (2021) Sulforaphane attenuates nonalcoholic fatty liver disease by inhibiting hepatic steatosis and apoptosis. Nutrients 14. https:\/\/doi.org\/10.3390\/NU14010076","DOI":"10.3390\/NU14010076"},{"key":"1116_CR141","doi-asserted-by":"publisher","unstructured":"song Xia Q, Wu F, Wu Wbin, Dong H, Huang Zyi, Xu L, Lu Fer, Gong J (2022) Berberine reduces hepatic ceramide levels to improve insulin resistance in HFD-fed mice by inhibiting HIF-2\u03b1. Biomed Pharmacother 150. https:\/\/doi.org\/10.1016\/J.BIOPHA.2022.112955","DOI":"10.1016\/J.BIOPHA.2022.112955"},{"key":"1116_CR142","doi-asserted-by":"publisher","unstructured":"Charytoniuk T, Sztolsztener K, Bielawiec P, Chabowski A, Konstantynowicz-Nowicka K, Harasim-Symbor E (2022) Cannabidiol downregulates myocardial de Novo ceramide synthesis pathway in a rat model of High-Fat Diet-Induced obesity. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/IJMS23042232","DOI":"10.3390\/IJMS23042232"},{"key":"1116_CR143","doi-asserted-by":"publisher","unstructured":"Reemst K, Broos JY, Abbink MR, Cimetti C, Giera M, Kooij G, Korosi A (2022) Early-life stress and dietary fatty acids impact the brain lipid\/oxylipin profile into adulthood, basally and in response to LPS. Front Immunol 13. https:\/\/doi.org\/10.3389\/FIMMU.2022.967437","DOI":"10.3389\/FIMMU.2022.967437"},{"key":"1116_CR144","doi-asserted-by":"publisher","unstructured":"Mah M, Febbraio S, Turpin-Nolan (2021) Circulating Ceramides- are origins important for sphingolipid biomarkers and treatments?? Front Endocrinol (Lausanne) 12. https:\/\/doi.org\/10.3389\/FENDO.2021.684448","DOI":"10.3389\/FENDO.2021.684448"},{"key":"1116_CR145","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","volume":"135","author":"DD Wang","year":"2017","unstructured":"Wang DD, Toledo E, Hruby A, Rosner BA, Willett WC, Sun Q, Razquin C, Zheng Y, Ruiz-Canela M, Guasch-Ferr\u00e9 M, Corella D, G\u00f3mez-Gracia E, Fiol M, Estruch R, Ros E, Lapetra J, Fito M, Aros F, Serra-Majem L, Lee CH, Clish CB, Liang L, Salas-Salvad\u00f3 J, Mart\u00ednez-Gonz\u00e1lez MA, Hu FB (2017) Plasma ceramides, mediterranean diet, and incident cardiovascular disease in the PREDIMED trial (Prevenci\u00f3n Con Dieta Mediterr\u00e1nea). Circulation 135:2028\u20132040. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024261","journal-title":"Circulation"},{"key":"1116_CR146","doi-asserted-by":"publisher","unstructured":"Koch G, Grammatikos S, Trautmann Y, Schreiber D, Thomas F, Bruns J, Pfeilschifter K, Badenhoop M, Penna-Martinez (2017) Vitamin D supplementation enhances C18(dihydro)ceramide levels in type 2 diabetes patients. Int J Mol Sci 18. https:\/\/doi.org\/10.3390\/IJMS18071532","DOI":"10.3390\/IJMS18071532"},{"key":"1116_CR147","doi-asserted-by":"publisher","unstructured":"Schmedes C, Balderas EK, Aadland H, Jacques C, Lavigne IE, Graff \u00d8, Eng A, Holthe G, Mellgren JF, Young UK, Sundekilde B, Liaset HC, Bertram (2018) The effect of Lean-Seafood and Non-Seafood diets on fasting and postprandial serum metabolites and lipid species: results from a randomized crossover intervention study in healthy adults. Nutrients 10. https:\/\/doi.org\/10.3390\/NU10050598","DOI":"10.3390\/NU10050598"},{"key":"1116_CR148","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1210\/JC.2019-00160","volume":"104","author":"F Rosqvist","year":"2019","unstructured":"Rosqvist F, Kullberg J, St\u00e5hlman M, Cedernaes J, Heurling K, Johansson HE, Iggman D, Wilking H, Larsson A, Eriksson O, Johansson L, Straniero S, Rudling M, Antoni G, Lubberink M, Orho-Melander M, Bor\u00e9n J, Ahlstr\u00f6m H (2019) Ris\u00e9rus, overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: A randomized trial. J Clin Endocrinol Metab 104:6207\u20136219. https:\/\/doi.org\/10.1210\/JC.2019-00160","journal-title":"J Clin Endocrinol Metab"},{"key":"1116_CR149","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/DOM.13773","volume":"21","author":"D Tuccinardi","year":"2019","unstructured":"Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Klapa MI, Candela M, Rampelli S, Lehoux S, L\u00e1zaro I, Sala-Vila A, Brigidi P, Cummings RD, Mantzoros CS (2019) Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross-over, randomized, double-blind, controlled inpatient physiology study. Diabetes Obes Metab 21:2086\u20132095. https:\/\/doi.org\/10.1111\/DOM.13773","journal-title":"Diabetes Obes Metab"},{"key":"1116_CR150","doi-asserted-by":"publisher","unstructured":"Zhu C, Sawrey-Kubicek L, Beals E, Hughes RL, Rhodes CH, Sacchi R, Zivkovic AM (2019) The HDL lipidome is widely remodeled by fast food versus mediterranean diet in 4 days. Metabolomics 15. https:\/\/doi.org\/10.1007\/S11306-019-1579-1","DOI":"10.1007\/S11306-019-1579-1"},{"key":"1116_CR151","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1210\/CLINEM\/DGAA459","volume":"105","author":"V Ferchaud-Roucher","year":"2020","unstructured":"Ferchaud-Roucher V, Zair Y, Aguesse A, Krempf M, Ouguerram K (2020) Omega 3 improves both apoB100-containing lipoprotein turnover and their sphingolipid profile in hypertriglyceridemia. J Clin Endocrinol Metab 105:3152\u20133164. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA459","journal-title":"J Clin Endocrinol Metab"},{"key":"1116_CR152","doi-asserted-by":"publisher","unstructured":"Chiu S, Siri-Tarino P, Bergeron N, Suh JH, Krauss RM (2020) A randomized study of the effect of replacing Sugar-Sweetened soda by reduced fat milk on cardiometabolic health in male adolescent soda drinkers. Nutrients 12. https:\/\/doi.org\/10.3390\/NU12020405","DOI":"10.3390\/NU12020405"},{"key":"1116_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NU12113586","volume":"12","author":"D Djekic","year":"2020","unstructured":"Djekic D, Shi L, Calais F, Carlsson F, Landberg R, Hy\u00f6tyl\u00e4inen T, Fr\u00f8bert O (2020) Effects of a Lacto-Ovo-Vegetarian diet on the plasma lipidome and its association with atherosclerotic burden in patients with coronary artery Disease-A randomized, Open-Label, Cross-over study. Nutrients 12:1\u201316. https:\/\/doi.org\/10.3390\/NU12113586","journal-title":"Nutrients"},{"key":"1116_CR154","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.JACL.2019.11.002","volume":"14","author":"M Averill","year":"2020","unstructured":"Averill M, Rubinow KB, Cain K, Wimberger J, Babenko I, Becker JO, Foster-Schubert KE, Cummings DE, Hoofnagle AN, Vaisar T (2020) Postprandial remodeling of high-density lipoprotein following high saturated fat and high carbohydrate meals. J Clin Lipidol 14:66\u201376e11. https:\/\/doi.org\/10.1016\/J.JACL.2019.11.002","journal-title":"J Clin Lipidol"},{"key":"1116_CR155","doi-asserted-by":"publisher","unstructured":"Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H (2020) Vitamin D3 supplementation increases Long-Chain ceramide levels in overweight\/obese African americans: A Post-Hoc analysis of a randomized controlled trial. Nutrients 12. https:\/\/doi.org\/10.3390\/NU12040981","DOI":"10.3390\/NU12040981"},{"key":"1116_CR156","doi-asserted-by":"publisher","unstructured":"Kwon YJ, Lee GM, Liu KH, Jung DH (2021) Effect of Korean Red Ginseng on Plasma Ceramide Levels in Postmenopausal Women with Hypercholesterolemia: A Pilot Randomized Controlled Trial, Metabolites 11 https:\/\/doi.org\/10.3390\/METABO11070417","DOI":"10.3390\/METABO11070417"},{"key":"1116_CR157","doi-asserted-by":"publisher","unstructured":"Lindqvist HM, B\u00e4rebring L, Gjertsson I, Jylh\u00e4 A, Laaksonen R, Winkvist A, Hilvo M (2021) A randomized controlled dietary intervention improved the serum lipid signature towards a less atherogenic profile in patients with rheumatoid arthritis. Metabolites 11. https:\/\/doi.org\/10.3390\/METABO11090632","DOI":"10.3390\/METABO11090632"},{"key":"1116_CR158","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/J.CLNU.2020.10.014","volume":"40","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Xu H, Tian Z, Wang X, Xu L, Li K, Gao X, Fan D, Ma X, Ling W, Yang Y (2021) Dose-dependent reductions in plasma ceramides after anthocyanin supplementation are associated with improvements in plasma lipids and cholesterol efflux capacity in dyslipidemia: A randomized controlled trial. Clin Nutr 40:1871\u20131878. https:\/\/doi.org\/10.1016\/J.CLNU.2020.10.014","journal-title":"Clin Nutr"},{"key":"1116_CR159","doi-asserted-by":"publisher","unstructured":"Le Barz M, Vors C, Combe E, Joumard-Cubizolles L, Lecomte M, Joffre F, Trauchessec M, Pesenti S, Loizon E, Breyton AE, Meugnier E, Bertrand K, Drai J, Robert C, Durand A, Cuerq C, Gaborit P, Leconte N, Bernalier-Donadille A, Cotte E, Laville M, Lambert-Porcheron S, Ouchchane L, Vidal H, Malpuech-Brug\u00e8re C, Cheillan D, Michalski MC (2021) Milk Polar lipids favorably alter Circulating and intestinal ceramide and sphingomyelin species in postmenopausal women. JCI Insight 6. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.146161","DOI":"10.1172\/JCI.INSIGHT.146161"},{"key":"1116_CR160","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.BIOCHI.2022.07.003","volume":"203","author":"MM Boulet","year":"2022","unstructured":"Boulet MM, Calzada C, Pettazzoni M, Lelekov-Boissard T, Buisson C, Di Filippo M, Durand A, Lambert-Porcheron S, Nazare JA, Moulin P, Michalski MC, Cheillan D (2022) A meal rich in palm oil or butter modifies the sphingolipid profile of postprandial triglyceride-rich lipoproteins from type 2 diabetic women. Biochimie 203:11\u201319. https:\/\/doi.org\/10.1016\/J.BIOCHI.2022.07.003","journal-title":"Biochimie"},{"key":"1116_CR161","doi-asserted-by":"publisher","unstructured":"Madkour MI, Islam MT, Tippetts TS, Chowdhury KH, Lesniewski LA, Summers SA, Zeb F, Abdelrahim DN, AlKurd R, Khraiwesh HM, AbuShihab KH, AlBakri A, Obaideen K, Faris MAIE (2023) Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma sphingolipids\/ceramides in subjects with obesity: lipidomics analysis. Sci Rep 13. https:\/\/doi.org\/10.1038\/S41598-023-43862-9","DOI":"10.1038\/S41598-023-43862-9"},{"key":"1116_CR162","doi-asserted-by":"publisher","unstructured":"Tate BN, Van Guilder GP, Aly M, Spence LA, Diaz-Rubio ME, Le HH, Johnson EL, McFadden JW, Perry CA (2023) Changes in choline metabolites and ceramides in response to a DASH-Style diet in older adults. Nutrients 15. https:\/\/doi.org\/10.3390\/NU15173687","DOI":"10.3390\/NU15173687"},{"key":"1116_CR163","doi-asserted-by":"publisher","unstructured":"Daidone M, Casuccio A, Puleo MG, Del Cuore A, Pacinella G, Di Chiara T, Di Raimondo D, Immordino P, Tuttolomondo A (2024) Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides. PLoS ONE 19. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0300844","DOI":"10.1371\/JOURNAL.PONE.0300844"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-025-01116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-025-01116-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-025-01116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:45:10Z","timestamp":1766555110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-025-01116-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":163,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1007\/s13105-025-01116-4","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review article was not subject to any ethics approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication of this review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}